MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

AstraZeneca plc Company Profile (NYSE:AZN)

Consensus Ratings for AstraZeneca plc (NYSE:AZN) (?)
Ratings Breakdown: 2 Sell Rating(s), 7 Hold Rating(s), 13 Buy Rating(s), 2 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $39.50 (37.68% upside)

Current Analysts' Coverage Summary for AstraZeneca plc (NYSE:AZN)
Show:
DateFirmActionRatingPrice TargetActions
2/8/2016HSBCDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016Beaufort SecuritiesReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016Sanford C. BernsteinLower Price Target$34.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016Goldman SachsReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016Leerink SwannReiterated RatingMarket Perform$37.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2016Oddo & CieUpgradeNeutral -> Top PickView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2016Oddo SecuritiesUpgradeNeutral -> Top PickView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016BarclaysUpgradeUnderweight -> Equal Weight$44.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2016Deutsche BankReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2016Credit SuisseReiterated RatingUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2015Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/30/2015BNP ParibasReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Nordea Equity ResearchDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2015Bank of AmericaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2015Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2015Bryan Garnier & CieUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015S&P Equity ResearchUpgradeBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015SwedbankUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015Berenberg BankUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015Kepler Capital MarketsReiterated RatingReduceView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Liberum CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2015Societe GeneraleInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/13/2015Shore CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015Panmure GordonReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015DanskeDowngradeSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2015SEB Equity ResearchUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2014Prime WealthReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2014Galvan ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/8/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha